Henry Ji
Shugaba, Shugaba da Shugaba
- 25+ shekaru na gwaninta a cikin fasahar kere-kere da masana'antar kimiyyar rayuwa
- Dokta Ji ya kafa Sorrento kuma ya kasance darekta tun 2006, Shugaba da Shugaba tun 2012, kuma Shugaba tun 2017.
- A lokacin da yake aiki a Sorrento, ya ƙware kuma ya jagoranci babban ci gaban Sorrento ta hanyar saye da haɗewa ciki har da Bioserv, Scilex Pharmaceuticals, Concortis Biotherapeutics, Levena Biopharma, LACEL, TNK Therapeutics, Virttu Biologics, Ark Debelopment Lymive Health, da Sorry Animal Health Systems, da Sorrento.
- Ya yi aiki a matsayin Babban Jami'in Kimiyya na Sorrento daga 2008 zuwa 2012 kuma a matsayin Shugaba na riko daga 2011 zuwa 2012
- Kafin Sorrento, ya rike manyan mukamai a CombiMatrix, Stratagene sannan kuma ya kafa Stratagene Genomics, reshen Stratagene, kuma ya yi aiki a matsayin Shugaba & Shugaba da Daraktan Hukumar.
- BS da Ph.D.
Rufe >
Mike Royal
Chief Medical Officer
- Dokta Royal babban jami'in harhada magunguna ne tare da shekaru 20 na ci gaban asibiti da lamuran lafiya. Kwanan nan, shi ne babban jami'in kula da lafiya na Suzhou Connect Biopharmaceuticals kuma, kafin wannan, Concentric Analgesics. Ya koma Sorrento inda a baya ya kasance EVP, Ci gaban Clinical da Harkokin Gudanarwa a cikin 2016
- Ya kasance mai alhakin ko kuma kayan aiki a cikin NDA da yawa masu nasara, ciki har da NCEs, 505 (b) (2) s da ANDAs.
- Dokta Royal yana da takardar shaidar likitancin ciki, maganin ciwo, anesthesiology tare da ƙarin cancantar kula da ciwo, maganin jaraba da likitancin doka.
- Ya kasance Mataimakin Farfesa na Magunguna a Jami'ar Uniformed Services University of Health Sciences, Mataimakin Farfesa na Anesthesiology/Critical Care Medicine a Jami'ar Pittsburgh Medical Center, kuma Farfesa Farfesa a Jami'ar Oklahoma da Jami'ar California San Diego.
- Ya buga da yawa tare da surori na littattafai sama da 190, abubuwan da suka yi bitar takwarorinsu da ƙasidu / fastoci; kuma ya kasance mai jawabi gayyata a tarukan kasa da kasa
- BS, MD, JD, MBA
Rufe >
Elizabeth Cerepak
Mataimakin shugaban kasa, babban jami'in kudi, babban jami'in kasuwanci
- Shekaru 35+ na ƙwarewar kuɗi da aiki a cikin fasahar kere-kere da magunguna
- Ms. Czerepak ta shafe shekaru 18 a babban Pharma da shekaru 11 a matsayin CFO na fasahar kere-kere daban-daban, inda ta jagoranci bayar da kudade, hadin gwiwa da kokarin M&A. Ta fara aikinta a Merck & Co., ta taka muhimmiyar rawa a siyan $5.4B na Roche na Syntex, kuma ta jagoranci ƙoƙarin haɗin gwiwa don Humira® wanda ya ƙare a cinikin BASF Pharma na $6.8B ga Abbott.
- Tsawon shekaru tara a matsayin Manajan Darakta a JP Morgan da Bear Stearns, ta kasance babban abokin tarayya na asusun kasuwanci na $212M, inda ta jagoranci saka hannun jari a cikin fasahar kere-kere guda 13, tana aiki a kan allo da sauƙaƙe fita ta hanyar IPO da saye. Jerin 7 da Series 63 FINRA (NASD) Wakilin Rajista daga 2001 zuwa 2008.
- Gogaggen memba na hukumar (ciki har da Sorrento da Scilex) da shugabar tantancewa, suna samun Takaddun Darakta na Kamfanin daga Makarantar Kasuwancin Harvard a cikin 2020.
- BA dan MBA
Rufe >
Mark R. Brunswick
Babban Mataimakin Shugaban Kasa Kan Ka'ida
- Dr. Brunswick yana da fiye da shekaru 35 na manyan mukamai a Masana'antu da aka Kayyade ciki har da fiye da shekaru 9 a cikin FDA ta Amurka, Cibiyar Nazarin Halittu, Sashen Kwayoyin cuta na Monoclonal
- Kafin shiga Sorrento, Dr. Brunswick ya kasance Shugaban Harkokin Gudanarwa da Ingantawa a Sophiris Bio, wani kamfani da ke haɓaka maganin cutar hawan jini na prostate da ciwon prostate. Kafin haka ya kasance shugaban kula da harkokin gudanarwa a Arena Pharmaceuticals ƙwararre a cikin hanyoyin kwantar da hankali da aka ba da umarni ga masu karɓar Protein G.
- Dr. Brunswick ya jagoranci ƙungiyar masu gudanarwa a Elan Pharmaceuticals da ke mayar da hankali kan cutar Alzheimer da fili mai zafi, ziconotide.
- BS da Ph.D.
Rufe >
Xiao Xu
Shugaban ACEA
- Dr. Xu yana da kwarewa fiye da shekaru 20 a matsayin mai gudanarwa a masana'antun fasahar kere kere. Dokta Xu ya kasance mai haɗin gwiwa, shugaba kuma Shugaba na ACEA Biosciences (wanda Agilent ya samu a cikin 2018) da ACEA Therapeutics (wanda aka samu ta hanyar Agilent). Sorrento Therapeutics a 2021). Yana shiga Sorrento Therapeutics bayan saye, kuma ya ci gaba da aiki a matsayin Shugaban ACEA, reshen na Sorrento Therapeutics.
- Ya kasance yana gudanarwa kuma yana da alhakin haɓaka bututun magunguna na ACEA, nazarin asibiti, da kayan aikin cGMP.
- Shi ne wanda ya kirkiri sabbin lakabin fasahar tantance tantanin halitta kyauta kuma ke da alhakin fasahar / haɓaka samfuri da haɗin gwiwar kasuwanci tare da Roche Diagnosis, kasuwancin duniya na fasahar mallakar ACEA da samfuran, da $250 miliyan Agilent sayan ACEA Biosciences.
- Ya kasance mai binciken ma'aikata kuma masanin kimiyyar bincike a Cibiyoyin Gladstone, Cibiyar Nazarin Scripps da Cibiyar Kula da Cututtuka ta Amurka. Ya mallaki fiye da 50 na Amurka haƙƙin mallaka da aikace-aikacen haƙƙin mallaka kuma ya buga sama da kasidu 60 na bincike a cikin mujallu na duniya, waɗanda suka haɗa da Kimiyya, PNAS, Nature Biotechnology, da Chemistry da Biology.
- BS, MS, da MD
Rufe >
Shawn Sahabi
Babban Mataimakin Shugaban Kasuwancin Kasuwanci
- Dokta Sahebi ya jagoranci ayyukan kasuwanci na Sorrento
- Ya kawo fiye da shekaru 30 na ƙwarewar magunguna gami da kimiyyar talla da dabarun kasuwanci zuwa Sorrento
- Kafin shiga Sorrento, ya rike manyan mukamai na gudanarwa tare da Novartis, Pfizer, da Lilly suna haɓaka nazarin kasuwanci da dabarun tallan tallace-tallace da ke haifar da gagarumin ci gaban tallace-tallace na samfuran sama da 20 waɗanda suka kai matsayin blockbuster a cikin wuraren cututtukan zuciya, Arthritis, Neuroscience, Ciwon sukari, da Oncology
- Mai cikakken imani cewa al'adun haɗin gwiwa suna haifar da ƙungiyoyi masu nasara
- Shugaban da ya gabata, Ƙungiyar Kimiyyar Gudanar da Magunguna ta Amurka
- BA, MBA dan Ph.D.
Rufe >
Brian Kuley
Babban Mataimakin Shugaban Kasa, Sadarwar Kasuwanci da Ci gaban Magungunan Lymphatic BU
- 30+ shekaru na gwaninta a cikin masana'antar biopharmaceutical da kimiyyar rayuwa
- Mista Cooley ya gudanar da tallace-tallace daban-daban, tallace-tallace, da kuma jagoranci na kasuwanci a kamfanoni 500 na arziki kuma ya jagoranci samar da kudade mai nasara da fara kokarin kamfanonin fasaha na kiwon lafiya.
- Kafin shiga Sorrento, Mista Cooley ya jagoranci tallan tallace-tallace na duniya sabon ƙoƙarin ƙaddamar da samfurin tare da alhakin P & L a duka Eli Lilly da Kamfanin da Genentech a yankunan cututtuka ciki har da Ciwon sukari, Neurology, Immunology da Rare Disease
- Bugu da kari, ya kuma jagoranci gagarumin BD, in-lasisi, da yunƙurin haɗin kai a duk duniya da kuma a cikin Amurka Wannan ya haɗa da yarjejeniyar fadada kasuwanci da yawa Turai, Gabas ta Tsakiya da Afirka, da yarjejeniyar haɗin gwiwar $ 400MM don samun lasisi, haɓakawa da kasuwanci. GLP-1 agonist na farko
- Kwanan nan, Mista Cooley ya kasance CBO don Sashin Kasuwancin Sofusa a Kimberly-Clark kuma ya jagoranci yunƙurin siyarwa da haɗin kai cikin nasara. Sorrento Therapeutics. Ya ci gaba da jagorantar sashin tsarin Isar da Magungunan Lymphatic a Sorrento.
- BS
Rufe >
Bill Farley
Mataimakin Shugaban Ƙasa Kasuwanci
- 30 + shekaru na gwaninta a cikin Ci gaban Kasuwancin, Tallace-tallace da manyan ƙoƙarin gano magunguna, haɓakawa da haɗin gwiwa
- Kafin shiga Sorrento, Mista Farley ya rike mukamai na jagoranci a HitGen, WuXi Apptec, VP na Gine-ginen Mahimmin Asusun da kuma jagorantar ƙungiyar BD na duniya; ChemDiv, VP na BD a, yana jagorantar ƙoƙarce-ƙoƙarce da yawa don ƙirƙirar sabbin kamfanonin warkewa a cikin CNS, Oncology da Anti-infectives.
- Mista Farley ya yi aiki a matsayin mai ba da shawara ga ƙungiyoyin gudanarwa daban-daban da BODs don haɓakawa da tallace-tallacen kadarorin tare da irin su Xencor, Caliper Technologies da Stratagene.
- Ya gina hanyar sadarwa mai ƙarfi a cikin kamfanonin harhada magunguna, fasahar kere-kere da al'ummar Venture Capital. Mista Farley ya yi magana a tarurruka da yawa kuma an buga shi a cikin mujallu daban-daban da aka bita
- BS
Rufe >
Alexis Nahama
Babban Mataimakin Shugaban Neurotherapeutics BU
- Dokta Nahama ya jagoranci shirye-shiryen bunkasa magungunan lafiyar ɗan adam da na dabbobi na RTX
- A matsayin ƙungiyar jagoranci memba, Dr. Nahama yana goyan bayan haɓaka dabarun, kula da ayyuka masu ƙima, sauƙaƙe zuwa shirye-shiryen kasuwa, da haɓaka ƙoƙarin haɗin gwiwa na waje.
- Cike da sha'awa yana fitar da damar fassara don haɓaka shirye-shiryen ci gaban ɗan adam yayin da ake kawo fasahohin da in ba haka ba ba za su samu ga dabbobi ba.
- Kafin shiga Sorrento, ya shafe fiye da shekaru 25 yana rike da ayyukan zartarwa na duniya yana aiki a Kimiyyar Rayuwa da Kimiyyar Halitta don Sanofi, Colgate, Novartis, Merck, VCA Antech da VetStem Biopharma
- DVM tare da aikin farko da aka mayar da hankali kan R&D a cikin yankin zafi (gwajin asibiti don dabbobi)
Rufe >
10bio yana zuwa nan10: dangler l=5